News

Robitussin sued over non-drowsy claims. Are you owed part of $4.5M settlement?
Anyone in the U.S. who bought any flavor Robitussin product containing dextromethorphan (or DXM) and labeled as “non-drowsy” between Feb. 16, 2016, and Jan. 21 are eligible to file a claim, according ...
American Association of Individual Investors1d
Why Vir Biotechnology, Inc.’s (VIR) Stock Is Up 5.82%
Vir Biotechnology, Inc.’s VIR share price has surged by 5.82%, which has investors questioning if this is right time to sell.
Targeted Oncology3d
Improving Quality of Life in LR-MDS Through Anemia Treatment
During a live event, Chris Benton, MD, discussed the focus on anemia management, reducing transfusions, and improving quality ...
Chemotherapy-Induced Nausea and Vomiting Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight
Induced Nausea and Vomiting Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth ...
Thyroid Cancer Drugs Industry And Companies Analysis Report 2025: A $2.2 Billion Landscape By 2029
The market is characterized by trends such as personalized medicine, targeted therapies, and combination treatments. Key players include Eli Lilly, B ...
American Association of Individual Investors6d
Why Coherus BioSciences, Inc.’s (CHRS) Stock Is Down 5.19%
Coherus BioSciences, Inc.’s CHRS share price has dipped by 5.19%, which has investors questioning if this is right time to ...
Le Lézard5d
Aldeyra Therapeutics Appoints Chip Clark to Board of Directors
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the ...
Conventus Law6d
US – Hikma And Amici Curiae Ask Supreme Court To Revisit Induced Infringement by Generic “Skinny Labels”.
US - Hikma And Amici Curiae Ask Supreme Court To Revisit Induced Infringement by Generic “Skinny Labels”. Legal News and ...